Iridex Stock Cash And Equivalents

IRIX Stock

USD 1.77 0.03 1.67%

IRIDEX fundamentals help investors to digest information that contributes to IRIDEX's financial success or failures. It also enables traders to predict the movement of IRIDEX Stock. The fundamental analysis module provides a way to measure IRIDEX's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IRIDEX stock.

Other Current Liab Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

IRIDEX Company Cash And Equivalents Analysis

IRIDEX's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Cash

Bank Deposits

+

Liquidities

More About Cash And Equivalents | All Equity Analysis

Current IRIDEX Cash And Equivalents

17.97 M

Most of IRIDEX's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IRIDEX is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

IRIDEX Cash And Equivalents Driver Correlations

Understanding the fundamental principles of building solid financial models for IRIDEX is extremely important. It helps to project a fair market value of IRIDEX Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since IRIDEX's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of IRIDEX's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of IRIDEX's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Short Term Debt	Net Tangible Assets	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Debt Total	Short Long Term Debt
Total Assets		0.66	-0.72	-0.26	0.47	0.88	0.47	0.96	0.31	0.55	0.09	0.63	-0.72	-0.91	0.39	0.27	-0.07	0.11	0.25	-0.03	-0.03
Total Stockholder Equity	0.66		-0.79	0.48	-0.26	0.43	-0.35	0.67	-0.35	-0.01	-0.39	0.03	-0.59	-0.59	0.84	-0.28	0.61	0.58	-0.55	0.52	0.52
Net Debt	-0.72	-0.79		-0.14	0.1	-0.46	0.02	-0.83	0.01	-0.25	0.0	-0.4	0.45	0.62	-0.59	-0.07	-0.43	-0.56	0.24	-0.44	-0.44
Retained Earnings	-0.26	0.48	-0.14		-0.76	-0.51	-0.9	-0.25	-0.63	-0.81	-0.56	-0.67	0.19	0.38	0.67	-0.88	0.9	0.77	-0.84	0.56	0.56
Accounts Payable	0.47	-0.26	0.1	-0.76		0.63	0.87	0.39	0.63	0.58	0.24	0.67	-0.34	-0.5	-0.38	0.51	-0.74	-0.55	0.84	-0.72	-0.72
Net Receivables	0.88	0.43	-0.46	-0.51	0.63		0.6	0.79	0.35	0.78	0.22	0.67	-0.62	-0.87	0.17	0.56	-0.4	-0.26	0.41	-0.15	-0.15
Total Liab	0.47	-0.35	0.02	-0.9	0.87	0.6		0.4	0.83	0.74	0.6	0.77	-0.2	-0.44	-0.53	0.7	-0.81	-0.54	0.95	-0.6	-0.6
Total Current Assets	0.96	0.67	-0.83	-0.25	0.39	0.79	0.4		0.22	0.5	0.05	0.61	-0.72	-0.88	0.42	0.28	0.02	0.17	0.16	0.01	0.01
Intangible Assets	0.31	-0.35	0.01	-0.63	0.63	0.35	0.83	0.22		0.57	0.68	0.59	0.03	-0.19	-0.59	0.46	-0.61	-0.22	0.83	-0.25	-0.25
Common Stock	0.55	-0.01	-0.25	-0.81	0.58	0.78	0.74	0.5	0.57		0.59	0.75	-0.34	-0.63	-0.35	0.91	-0.7	-0.52	0.59	-0.09	-0.09
Property Plant Equipment	0.09	-0.39	0.0	-0.56	0.24	0.22	0.6	0.05	0.68	0.59		0.49	0.36	0.01	-0.44	0.64	-0.56	-0.29	0.64	-0.13	-0.13
Current Deferred Revenue	0.63	0.03	-0.4	-0.67	0.67	0.67	0.77	0.61	0.59	0.75	0.49		-0.28	-0.64	-0.16	0.68	-0.48	-0.21	0.62	-0.28	-0.28
Good Will	-0.72	-0.59	0.45	0.19	-0.34	-0.62	-0.2	-0.72	0.03	-0.34	0.36	-0.28		0.84	-0.24	-0.12	0.04	0.11	0.03	0.05	0.05
Short Term Debt	-0.91	-0.59	0.62	0.38	-0.5	-0.87	-0.44	-0.88	-0.19	-0.63	0.01	-0.64	0.84		-0.26	-0.4	0.16	0.08	-0.19	0.03	0.03
Net Tangible Assets	0.39	0.84	-0.59	0.67	-0.38	0.17	-0.53	0.42	-0.59	-0.35	-0.44	-0.16	-0.24	-0.26		-0.49	0.74	0.63	-0.62	0.31	0.31
Capital Surpluse	0.27	-0.28	-0.07	-0.88	0.51	0.56	0.7	0.28	0.46	0.91	0.64	0.68	-0.12	-0.4	-0.49		-0.77	-0.67	0.59	-0.22	-0.22
Net Invested Capital	-0.07	0.61	-0.43	0.9	-0.74	-0.4	-0.81	0.02	-0.61	-0.7	-0.56	-0.48	0.04	0.16	0.74	-0.77		0.9	-0.85	0.6	0.6
Net Working Capital	0.11	0.58	-0.56	0.77	-0.55	-0.26	-0.54	0.17	-0.22	-0.52	-0.29	-0.21	0.11	0.08	0.63	-0.67	0.9		-0.58	0.6	0.6
Capital Stock	0.25	-0.55	0.24	-0.84	0.84	0.41	0.95	0.16	0.83	0.59	0.64	0.62	0.03	-0.19	-0.62	0.59	-0.85	-0.58		-0.69	-0.69
Long Term Debt Total	-0.03	0.52	-0.44	0.56	-0.72	-0.15	-0.6	0.01	-0.25	-0.09	-0.13	-0.28	0.05	0.03	0.31	-0.22	0.6	0.6	-0.69		1.0
Short Long Term Debt	-0.03	0.52	-0.44	0.56	-0.72	-0.15	-0.6	0.01	-0.25	-0.09	-0.13	-0.28	0.05	0.03	0.31	-0.22	0.6	0.6	-0.69	1.0

Click cells to compare fundamentals

Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Competition

Predict IRIDEX

IRIDEX Cash And Cash Equivalents Changes

Cash And Cash Equivalents Changes

(737,865)

At this time, IRIDEX's Cash And Cash Equivalents Changes is fairly stable compared to the past year.

In accordance with the recently published financial statements, IRIDEX has 17.97 M in Cash And Equivalents. This is 97.81% lower than that of the Health Care Equipment & Supplies sector and 96.78% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 99.33% higher than that of the company.

IRIDEX Cash And Equivalents Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IRIDEX's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IRIDEX could also be used in its relative valuation, which is a method of valuing IRIDEX by comparing valuation metrics of similar companies.

IRIDEX is currently under evaluation in cash and equivalents category among its peers.

IRIDEX Fundamentals

	Return On Equity	-1.5
	Return On Asset	-0.21
	Profit Margin	(0.23) %
	Operating Margin	(0.16) %
	Current Valuation	30.99 M
	Shares Outstanding	16.64 M
	Shares Owned By Insiders	20.67 %
	Shares Owned By Institutions	20.05 %
	Number Of Shares Shorted	309.83 K
	Price To Earning	(6.30) X
	Price To Book	11.42 X
	Price To Sales	0.62 X
	Revenue	51.87 M
	Gross Profit	25.37 M
	EBITDA	(7.45 M)
	Net Income	(9.57 M)
	Cash And Equivalents	17.97 M
	Cash Per Share	1.12 X
	Total Debt	2.75 M
	Debt To Equity	0.11 %
	Current Ratio	3.19 X
	Book Value Per Share	0.16 X
	Cash Flow From Operations	(6.75 M)
	Short Ratio	9.64 X
	Earnings Per Share	(0.67) X
	Price To Earnings To Growth	(0.44) X
	Target Price	2.0
	Number Of Employees	111
	Beta	0.81
	Market Capitalization	29.95 M
	Total Asset	34.44 M
	Retained Earnings	(79.04 M)
	Working Capital	14.48 M
	Current Asset	30.77 M
	Current Liabilities	7.43 M
	Net Asset	34.44 M

About IRIDEX Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze IRIDEX's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IRIDEX using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IRIDEX based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for IRIDEX Stock Analysis

When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC